On 12 May 2017, the Chinese Food and Drug Administration (the “CFDA”) issued several draft policies aimed at overhauling of the current regulations governing the Chinese pharma and medical device sector (the “Draft Policies”). Amongst the Draft Policies, those outlined in Circular No.55 would, if implemented, establish a more robust patent linkage system, a more
Latest Post
More Posts
China’s OEM jurisprudence 1.5 years after the Pretul case: OEM use may still infringe upon Chinese trademarks
China’s OEM jurisprudence 1.5 years after the Pretul case: OEM use may still infringe upon Chinese trademarks
China’s OEM jurisprudence 1.5 years after the Pretul case: OEM use may still infringe upon Chinese trademarks
Every cent counts: China slashes certain IP application fees as of 1 April
Every cent counts: China slashes certain IP application fees as of 1 April
Every cent counts: China slashes certain IP application fees as of 1 April
IP aspects of China’s new controversial Cyber Security Law
No place to hide in Chinese cyber space – new rules regulate online advertising
Towards a Greater Chinese Firewall? – China issues new draft domain name rules
Subscribe: Subscribe via RSS